Belarus
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Belarus (BY)
| 2011 | 676.6 thousand |
| 2024 | 445.4 thousand |
| 2050 | 432.2 thousand |
Belarus is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS Belarus 2016
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 676.6 | 445.4 | 432.2 |
| Age-standardised prevalence of diabetes, % | - | 8.0 | 5.1 | 5.8 |
| Proportion of people with undiagnosed diabetes, % | - | - | 29.1 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 129.6 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 359.2 | 320.7 |
| Age-standardised prevalence of IFG, % | - | - | 4.5 | 4.8 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 802.0 | 173.8 | 139.6 |
| Age-standardised prevalence of IGT, % | - | 10.1 | 1.9 | 1.9 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 10,045.0 | 3,660.5 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 4.9 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 540.3 | 488.9 |
| Total diabetes-related health expenditure, ID million | - | - | 1,717.7 | 1,554.3 |
| Diabetes-related health expenditure per person, USD | - | 412.0 | 1,213.2 | 1,131.4 |
| Diabetes-related health expenditure per person, ID | - | - | 3,856.5 | 3,596.5 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 27,792.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 5,223.2 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 7,239.1 | 7,049.3 | 6,113.5 |
| Population of children and adolescents (0-19 y) | - | - | 1,962,244.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
